Relation builds causal AI for drug discovery

New foundation model and an expanded GSK partnership reflect a growing shift from observational biology towards mechanistic understanding. Artificial intelligence has become an increasingly familiar fixture in drug discovery, but not all biological models are asking the same question. Many seek patterns within vast observational datasets – identifying associations between genes, cells and disease. Relation […] The post Relation builds causal AI for drug discovery appeared first on Longevity.Technology .

This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.